Evotec AG today announced that it is adjusting its guidance regarding Group revenues. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/ad-hoc-releases/p/evotec-ag-results-of-pre-clinical-studies-lead-to-reduction-in-revenues-nevertheless-profitable-and-more-than-eur-90-m-cash-for-2013-confirmed-5612